Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5165-5178

  McClellan, Michael J ^a   Khasnis, Sarika ^a,c   David Wood, C ^a   Palermo, Richard D ^a   Kanhere, Sandra N Schlick ^a,d   Jenner, Richard G ^b   West, Michelle J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Research Center Borstel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 3C; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTONE H3; INTEGRIN RECEPTOR; LYSINE; UNCLASSIFIED DRUG;

ADAM28 GENE; ADAMDEC1 GENE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CCL3 GENE; CCL4 GENE; CELL ADHESION; CELL IMMORTALIZATION; CELL MIGRATION; CONTROLLED STUDY; CXCL10 GENE; CXCL11 GENE; EPSTEIN BARR VIRUS; GENE; GENE CONTROL; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; ITGA4 GENE; ITGB1 GENE; LYMPHOCYTE MIGRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS CELL INTERACTION;

ADAM PROTEINS; ANIMALS; ANTIGENS, VIRAL; BINDING SITES; CELL ADHESION; CELL LINE; CELL MIGRATION INHIBITION; CHEMOKINES; CHEMOTAXIS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; INTEGRINS; MICE; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR3; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 4;

EID: 84861304914     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07161-11     Document Type: Article

References (59)

1. Allday MJ, Crawford DH, Thomas JA. 1993. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J. Gen. Virol. 74:361-369.
2. Alon R, et al. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243-1253.
3. Anderton E, et al. 2008. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27:421-433.
4. Bain M, Watson RJ, Farrell PJ, Allday MJ. 1996. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J. Virol. 70:2481-2489.
5. Bark-Jones SJ, Webb HM, West MJ. 2006. EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. Oncogene 25:1775-1785.
6. Bates EE, Fridman WH, Mueller CG. 2002. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12. Immunogenetics 54:96-105.
7. Bridges LC, et al. 2002. The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1. J. Biol. Chem. 277: 3784-3792.
8. Chen A, Zhao B, Kieff E, Aster JC, Wang F. 2006. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J. Virol. 80:10139-10150.
9. Choudhuri T, Verma SC, Lan K, Robertson ES. 2006. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 351:58-72.
10. Cotter MA, II, Robertson ES. 2000. Modulation of histone acetyltransferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha. Mol. Cell. Biol. 20:5722-5735.
11. Dominguez-Jiménez C, Sánchez-Aparicio P, Albar JP, Garcia-Pardo A. 1996. The alpha 4 beta 1 fibronectin ligands CS-1, Hep II, andRGDinduce different intracellular events in B lymphoid cells. Comparison with the effects of the endothelial ligand VCAM-1. Cell Adhes. Commun. 4:251-267.
12. Gregory CD, Rowe M, Rickinson AB. 1990. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71:1481-1495.
13. Hensbergen PJ, et al. 2005. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J. Immunother. 28:343-351.
14. Hertle ML, et al. 2009. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog. 5:e1000506.
15. Jabs WJ, Wagner HJ, Maurmann S, Hennig H, Kreft B. 2002. Inhibition of macrophage inflammatory protein-1 alpha production by Epstein-Barr virus. Blood 99:1512-1516.
16. Jiménez-Ramírez C, et al. 2006. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter. J. Virol. 80:11200-11208.
17. Kim I, Uchiyama H, Chauhan D, Anderson KC. 1994. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br. J. Haematol. 87:483-493.
18. Knight JS, Lan K, Subramanian C, Robertson ES. 2003. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J. Virol. 77:4261-4272.
19. Krauer KG, et al. 2004. The EBNA-3 gene family proteins disrupt the G2/M checkpoint. Oncogene 23:1342-1353.
20. Leao M, Anderton E, Wade M, Meekings K, Allday MJ. 2007. Epstein-Barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. J. Virol. 81:248-260.
21. Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M. 1994. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205:596-602.
22. Loetscher M, et al. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
23. Lucchesi W, et al. 2008. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. J. Virol. 82:7456-7466.
24. Luster AD, Leder P. 1993. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178:1057-1065.
25. Macartney-Coxson DP, et al. 2008. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 8:187.
26. Maier S, et al. 2006. Cellular target genes of Epstein-Barr virus nuclear antigen 2. J. Virol. 80:9761-9771.
27. Marshall D, Sample C. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
28. Maruo S, et al. 2006. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 103:19500-19505.
29. Maunders MJ, Petti L, Rowe M. 1994. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. J. Gen. Virol. 75:769-778.
30. Maurer M, von Stebut E. 2004. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36:1882-1886.
31. McGinn OJ, et al. 2011. Modulation of integrin alpha4beta1 by ADAM28 promotes lymphocyte adhesion and transendothelial migration. Cell Biol. Int. 35:1043-1053.
32. Mitsui Y, et al. 2006. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. Cancer Res. 66:9913-9920.
33. Nakayama T, et al. 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol. 78:1665-1674.
34. Ohtsuka T, et al. 2006. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int. J. Cancer 118:263-273.
35. Oostendorp RA, et al. 1995. VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells. Br. J. Haematol. 91:275-284.
36. Palermo RD, Webb HM, West MJ. 2011. RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathog. 7:e1002334.
37. Parker GA, et al. 1996. Epstein-Barr virus nuclear antigen (EBNA)3C isan immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13:2541-2549.
38. Parker GA, Touitou R, Allday MJ. 2000. Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis. Oncogene 19:700-709.
39. Paschos K, et al. 2009. Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 5:e1000492.
40. Radkov SA, et al. 1997. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J. Virol. 71:8552-8562.
41. Radkov SA, et al. 1999. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73:5688-5697.
42. Robertson ES, et al. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNAbinding protein Jκ. J. Virol. 69:3108-3116.
43. Sgadari C, et al. 1996. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. U. S. A. 93: 13791-13796.
44. Skalska L, White RE, Franz M, Ruhmann M, Allday MJ. 2010. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog. 6:e1000951.
45. Spender LC, Cornish GH, Sullivan A, Farrell PJ. 2002. Expression of transcription factor AML-2 (RUNX3, CBFα-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76:4919-4927.
46. Spender LC, et al. 2006. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. J. Gen. Virol. 87:2859-2867.
47. Tomkinson B, Robertson E, Kieff E. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
48. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ. 2001. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J. Virol. 75:7749-7755.
49. Waltzer L, Perricaudet M, Sergeant A, Manet E. 1996. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-Jκ-EBNA2-activated transcription by inhibiting the binding of RBP-Jκ to DNA. J. Virol. 70: 5909-5915.
50. Wang F, et al. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
51. West MJ, Webb HM, Sinclair AJ, Woolfson DN. 2004. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. J. Virol. 78:9431-9445.
52. White RE, et al. 2010. Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS One 5:e13979.
53. Xia T, et al. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68:1436-1442.
54. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
55. Zhang Y, et al. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R137.
56. Zhao B, et al. 2011. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. U. S. A. 108:337-342.
57. Zhao B, et al. 2006. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. U. S. A. 103:1900-1905.
58. Zhao B, Sample CE. 2000. Epstein-Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. J. Virol. 74:5151-5160.
59. Zhao B, et al. 2011. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc. Natl. Acad. Sci. U. S. A. 108:14902-14907.